{*}
Add news
March 2010 April 2010 May 2010 June 2010 July 2010
August 2010
September 2010 October 2010 November 2010 December 2010 January 2011 February 2011 March 2011 April 2011 May 2011 June 2011 July 2011 August 2011 September 2011 October 2011 November 2011 December 2011 January 2012 February 2012 March 2012 April 2012 May 2012 June 2012 July 2012 August 2012 September 2012 October 2012 November 2012 December 2012 January 2013 February 2013 March 2013 April 2013 May 2013 June 2013 July 2013 August 2013 September 2013 October 2013 November 2013 December 2013 January 2014 February 2014 March 2014 April 2014 May 2014 June 2014 July 2014 August 2014 September 2014 October 2014 November 2014 December 2014 January 2015 February 2015 March 2015 April 2015 May 2015 June 2015 July 2015 August 2015 September 2015 October 2015 November 2015 December 2015 January 2016 February 2016 March 2016 April 2016 May 2016 June 2016 July 2016 August 2016 September 2016 October 2016 November 2016 December 2016 January 2017 February 2017 March 2017 April 2017 May 2017 June 2017 July 2017 August 2017 September 2017 October 2017 November 2017 December 2017 January 2018 February 2018 March 2018 April 2018 May 2018 June 2018 July 2018 August 2018 September 2018 October 2018 November 2018 December 2018 January 2019 February 2019 March 2019 April 2019 May 2019 June 2019 July 2019 August 2019 September 2019 October 2019 November 2019 December 2019 January 2020 February 2020 March 2020 April 2020 May 2020 June 2020 July 2020 August 2020 September 2020 October 2020 November 2020 December 2020 January 2021 February 2021 March 2021 April 2021 May 2021 June 2021 July 2021 August 2021 September 2021 October 2021 November 2021 December 2021 January 2022 February 2022 March 2022 April 2022 May 2022 June 2022 July 2022 August 2022 September 2022 October 2022 November 2022 December 2022 January 2023 February 2023 March 2023 April 2023 May 2023 June 2023 July 2023 August 2023 September 2023 October 2023 November 2023 December 2023 January 2024 February 2024 March 2024 April 2024 May 2024 June 2024 July 2024 August 2024 September 2024 October 2024 November 2024 December 2024 January 2025 February 2025 March 2025 April 2025 May 2025 June 2025 July 2025 August 2025 September 2025 October 2025 November 2025 December 2025 January 2026 February 2026 March 2026 April 2026 May 2026 June 2026 July 2026 August 2026 September 2026 October 2026 November 2026
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
23
24
25
26
27
28
29
30
News Every Day |

FDA clears tiny surgical robot to remove bladder tumors

If a doctor finds a tumor in your bladder, you want to know what you're dealing with. Is it cancer? Has it reached the bladder muscle? The tissue removed during surgery helps answer those questions. Now, a tiny surgical robot could give doctors a clearer view of what's happening inside the bladder.

The FDA has authorized the Virtuoso Endoscopy System, developed by Nashville-based Virtuoso Surgical. It uses two needle-sized robotic arms to remove bladder lesions through the urethra, without cutting through the skin. The technology allows surgeons to remove many tumors in one piece, potentially giving pathologists better tissue samples to examine. This new approach to robotic bladder tumor removal could help doctors make more informed treatment decisions.

Missed CyberGuy LIVE? Watch the replay and discover 5 ways to travel smarter and save money.

Our free CyberGuy LIVE class, 5 Ways to Travel Smarter and Save Money, has ended, but you can still watch the full replay. Kurt "CyberGuy" Knutsson walks you through five practical ways to protect your phone and personal information, avoid common travel scams, find better deals, save money on bookings and use technology to make your travels easier and less stressful. No technical experience is needed.

Watch the free replay + downloadable checklist now at CyberGuyLive.com.

WOULD YOU TRUST A TINY DENTAL ROBOT?

The Virtuoso Endoscopy System uses a narrow medical instrument called a rigid endoscope, which enters the bladder through the urethra. At the tip are two miniature robotic arms made from a flexible metal alloy called nitinol. A surgeon controls both arms from a console. One arm lifts and holds the tumor while the other carefully separates it from the tissue underneath. This gives the surgeon two-handed control inside a very small space.

The technique is called en bloc resection, which means removing a tumor in one piece. Surgeons can already perform this procedure using conventional instruments, but it can be technically demanding. Virtuoso designed its system to make that approach easier to perform. The robot also relies entirely on the surgeon's movements. Unlike some autonomous surgical robots being tested in research settings, Virtuoso does not make surgical decisions or operate independently.

Bladder cancer affects thousands of Americans every year. The American Cancer Society estimates that approximately 84,530 people in the United States will receive a bladder cancer diagnosis in 2026. One of the most common procedures for evaluating and removing bladder tumors is called transurethral resection of bladder tumor, or TURBT. During conventional TURBT, surgeons often remove tumors in smaller fragments. While effective for many patients, that approach can disrupt the tissue's original structure. As a result, pathologists may have a harder time determining how deeply cancer has grown. That's particularly important when it comes to the bladder's muscle layer, called the detrusor muscle. Doctors need to know whether cancer has reached this muscle because that can change the recommended treatment.

Removing a lesion intact may preserve more of the information pathologists need. It can also allow them to examine the tissue around the tumor more clearly. Dr. Duke Herrell, a urologic surgeon and CEO of Virtuoso Surgical, explained the potential benefit in the company's FDA announcement. "Removing a tumor intact can provide a better tissue specimen, which supports clearer diagnosis and staging," Herrell said. For patients, a more complete tissue sample could help their medical team determine the next steps with greater confidence.

Virtuoso has already tested the system in human patients, and the early clinical findings are encouraging. In the first 20 patients enrolled in the company-sponsored VIABLE study at The Chinese University of Hong Kong, 94% of removed lesions contained detrusor muscle. That exceeded the study's predefined performance goal of 60%. Researchers also reported that surgical margins could be evaluated in 93% of malignant lesions. Surgical margins are the edges of the removed tissue. Examining them can help doctors assess whether cancer cells extend to the edge of the sample. However, being able to evaluate a margin does not necessarily mean it is free of cancer. The company reported no adverse events during the operations.

There are important limitations to these findings. The study involved a small number of patients at one medical center. The previously published first phase of the same VIABLE study involved six patients and recorded two postoperative adverse events. One patient experienced temporary urinary retention, while another developed a chest infection later linked to a separate esophageal tumor. The company also compared its results with previously published research on conventional bladder tumor removal.

However, the Virtuoso study did not directly compare the robot against traditional instruments in a randomized trial. Researchers still need larger studies to determine whether the system improves long-term outcomes or reduces the need for additional procedures.

BRAIN TUMOR FOUND DURING PREVENTIVE SCAN PUTS FULL-BODY MRIS BACK IN THE SPOTLIGHT

The FDA granted De Novo authorization for the Virtuoso Endoscopy System on October 30, 2026. The company publicly announced the decision on November 10. The authorization establishes a new FDA classification for robotic surgical instruments that operate through an endoscope inside the body. Specifically, the system is authorized to remove bladder lesions in adult patients and obtain tissue samples, including bladder muscle, to assist in diagnosing bladder cancer.

The decision follows the FDA's September 2025 Breakthrough Device Designation for the system. That earlier designation recognized the technology's potential and allowed the company to receive additional regulatory guidance during development. However, the new authorization does not establish that the robot improves survival rates or prevents cancer from returning. The system must also be operated by trained surgeons in an operating room.

Virtuoso Surgical plans a limited U.S. launch in 2027, starting with leading urology centers. The company has not announced which hospitals will receive the system first. That means patients may have to wait before the technology becomes available at their local hospital. Questions also remain about pricing and insurance coverage.

Virtuoso is exploring other potential applications for its miniature robotic instruments, including procedures involving the lungs. However, those uses remain experimental and have not received FDA authorization. For now, the company's focus is bladder surgery, where better tissue samples could help doctors evaluate cancer more accurately.

If you or someone you love is facing bladder cancer, this technology could eventually provide another surgical option. Its miniature robotic arms may help doctors obtain more complete tissue samples during the initial procedure. However, availability will be limited at first, and the early results still need confirmation in larger studies. The robot's FDA authorization also does not guarantee better results for every patient.

If you're discussing bladder tumor surgery with a urologist, ask whether en bloc resection might be appropriate for your situation. You should also ask how the surgeon plans to obtain enough tissue to determine whether cancer has reached the bladder muscle. Those answers can help you understand your options before surgery.

When you're facing a possible cancer diagnosis, getting accurate answers as early as possible can make a real difference. That's what I like about this technology. Virtuoso's tiny robotic arms could help surgeons collect better tissue samples without taking control away from the medical professional performing the operation. It's also encouraging to see the FDA authorize a system designed for such a specific surgical challenge. Still, 20 patients represent a very small study, and I want to see how this robot performs in larger trials before getting too excited about its potential. If the results hold up, this could become a valuable addition to the tools doctors use to diagnose bladder cancer.

Would you trust a surgeon using this new robotic system to remove a tumor, or would you prefer a conventional procedure until there's more evidence of its benefits? Let us know by writing to us at Cyberguy.com

Sign up for my FREE CyberGuy Newsletter

Copyright 2026 CyberGuy.com. All rights reserved.

Ria.city






Read also

Wild trail cam footage shows buck protecting a doe by tossing a bobcat giving chase with its antlers

Famed NYC restaurateur Keith McNally hospitalized after getting caught in France protest chaos

Flavio Bolsonaro claims judge ordered passports seized just 7 minutes after Brazil election loss

News, articles, comments, with a minute-by-minute update, now on Today24.pro

Today24.pro — latest news 24/7. You can add your news instantly now — here




Sports today


Новости тенниса


Спорт в России и мире


All sports news today





Sports in Russia today


Новости России


Russian.city



Губернаторы России









Путин в России и мире







Персональные новости
Russian.city





Friends of Today24

Музыкальные новости

Персональные новости